Global Liposomal Amphoteracin B Market Growth 2022-2028

1.1 Market Introduction

1.2 Years Considered

1.3 Research Objectives

1.4 Market Research Methodology

1.5 Research Process and Data Source

1.6 Economic Indicators

1.7 Currency Considered

2 Executive Summary

2.1 World Market Overview

2.1.1 Global Liposomal Amphoteracin B Annual Sales 2017-2028

2.1.2 World Current & Future Analysis for Liposomal Amphoteracin B by Geographic Region, 2017, 2022 & 2028

2.1.3 World Current & Future Analysis for Liposomal Amphoteracin B by Country/Region, 2017, 2022 & 2028

2.2 Liposomal Amphoteracin B Segment by Type

2.2.1 25mg

2.2.2 50mg

2.3 Liposomal Amphoteracin B Sales by Type

2.3.1 Global Liposomal Amphoteracin B Sales Market Share by Type (2017-2022)

2.3.2 Global Liposomal Amphoteracin B Revenue and Market Share by Type (2017-2022)

2.3.3 Global Liposomal Amphoteracin B Sale Price by Type (2017-2022)

2.4 Liposomal Amphoteracin B Segment by Application

2.4.1 Hospital

2.4.2 Pharmacy

2.5 Liposomal Amphoteracin B Sales by Application

2.5.1 Global Liposomal Amphoteracin B Sale Market Share by Application (2017-2022)

2.5.2 Global Liposomal Amphoteracin B Revenue and Market Share by Application (2017-2022)

2.5.3 Global Liposomal Amphoteracin B Sale Price by Application (2017-2022)

3 Global Liposomal Amphoteracin B by Company

3.1 Global Liposomal Amphoteracin B Breakdown Data by Company

3.1.1 Global Liposomal Amphoteracin B Annual Sales by Company (2020-2022)

3.1.2 Global Liposomal Amphoteracin B Sales Market Share by Company (2020-2022)

3.2 Global Liposomal Amphoteracin B Annual Revenue by Company (2020-2022)

3.2.1 Global Liposomal Amphoteracin B Revenue by Company (2020-2022)

3.2.2 Global Liposomal Amphoteracin B Revenue Market Share by Company (2020-2022)

3.3 Global Liposomal Amphoteracin B Sale Price by Company

3.4 Key Manufacturers Liposomal Amphoteracin B Producing Area Distribution, Sales Area, Product Type

3.4.1 Key Manufacturers Liposomal Amphoteracin B Product Location Distribution

3.4.2 Players Liposomal Amphoteracin B Products Offered

3.5 Market Concentration Rate Analysis

3.5.1 Competition Landscape Analysis

3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

3.6 New Products and Potential Entrants

3.7 Mergers & Acquisitions, Expansion

4 World Historic Review for Liposomal Amphoteracin B by Geographic Region

4.1 World Historic Liposomal Amphoteracin B Market Size by Geographic Region (2017-2022)

4.1.1 Global Liposomal Amphoteracin B Annual Sales by Geographic Region (2017-2022)

4.1.2 Global Liposomal Amphoteracin B Annual Revenue by Geographic Region

4.2 World Historic Liposomal Amphoteracin B Market Size by Country/Region (2017-2022)

4.2.1 Global Liposomal Amphoteracin B Annual Sales by Country/Region (2017-2022)

4.2.2 Global Liposomal Amphoteracin B Annual Revenue by Country/Region

4.3 Americas Liposomal Amphoteracin B Sales Growth

4.4 APAC Liposomal Amphoteracin B Sales Growth

4.5 Europe Liposomal Amphoteracin B Sales Growth

4.6 Middle East & Africa Liposomal Amphoteracin B Sales Growth

5 Americas

5.1 Americas Liposomal Amphoteracin B Sales by Country

5.1.1 Americas Liposomal Amphoteracin B Sales by Country (2017-2022)

5.1.2 Americas Liposomal Amphoteracin B Revenue by Country (2017-2022)

5.2 Americas Liposomal Amphoteracin B Sales by Type

5.3 Americas Liposomal Amphoteracin B Sales by Application

5.4 United States

5.5 Canada

5.6 Mexico

5.7 Brazil

6 APAC

6.1 APAC Liposomal Amphoteracin B Sales by Region

6.1.1 APAC Liposomal Amphoteracin B Sales by Region (2017-2022)

6.1.2 APAC Liposomal Amphoteracin B Revenue by Region (2017-2022)

6.2 APAC Liposomal Amphoteracin B Sales by Type

6.3 APAC Liposomal Amphoteracin B Sales by Application

6.4 China

6.5 Japan

6.6 South Korea

6.7 Southeast Asia

6.8 India

6.9 Australia

6.10 China Taiwan

7 Europe

7.1 Europe Liposomal Amphoteracin B by Country

7.1.1 Europe Liposomal Amphoteracin B Sales by Country (2017-2022)

7.1.2 Europe Liposomal Amphoteracin B Revenue by Country (2017-2022)

7.2 Europe Liposomal Amphoteracin B Sales by Type

7.3 Europe Liposomal Amphoteracin B Sales by Application

7.4 Germany

7.5 France

7.6 UK

7.7 Italy

7.8 Russia

8 Middle East & Africa

8.1 Middle East & Africa Liposomal Amphoteracin B by Country

8.1.1 Middle East & Africa Liposomal Amphoteracin B Sales by Country (2017-2022)

8.1.2 Middle East & Africa Liposomal Amphoteracin B Revenue by Country (2017-2022)

8.2 Middle East & Africa Liposomal Amphoteracin B Sales by Type

8.3 Middle East & Africa Liposomal Amphoteracin B Sales by Application

8.4 Egypt

8.5 South Africa

8.6 Israel

8.7 Turkey

8.8 GCC Countries

9 Market Drivers, Challenges and Trends

9.1 Market Drivers & Growth Opportunities

9.2 Market Challenges & Risks

9.3 Industry Trends

10 Manufacturing Cost Structure Analysis

10.1 Raw Material and Suppliers

10.2 Manufacturing Cost Structure Analysis of Liposomal Amphoteracin B

10.3 Manufacturing Process Analysis of Liposomal Amphoteracin B

10.4 Industry Chain Structure of Liposomal Amphoteracin B

11 Marketing, Distributors and Customer

11.1 Sales Channel

11.1.1 Direct Channels

11.1.2 Indirect Channels

11.2 Liposomal Amphoteracin B Distributors

11.3 Liposomal Amphoteracin B Customer

12 World Forecast Review for Liposomal Amphoteracin B by Geographic Region

12.1 Global Liposomal Amphoteracin B Market Size Forecast by Region

12.1.1 Global Liposomal Amphoteracin B Forecast by Region (2023-2028)

12.1.2 Global Liposomal Amphoteracin B Annual Revenue Forecast by Region (2023-2028)

12.2 Americas Forecast by Country

12.3 APAC Forecast by Region

12.4 Europe Forecast by Country

12.5 Middle East & Africa Forecast by Country

12.6 Global Liposomal Amphoteracin B Forecast by Type

12.7 Global Liposomal Amphoteracin B Forecast by Application

13 Key Players Analysis

13.1 Gilead Sciences

13.1.1 Gilead Sciences Company Information

13.1.2 Gilead Sciences Liposomal Amphoteracin B Product Offered

13.1.3 Gilead Sciences Liposomal Amphoteracin B Sales, Revenue, Price and Gross Margin (2020-2022)

13.1.4 Gilead Sciences Main Business Overview

13.1.5 Gilead Sciences Latest Developments

14 Research Findings and Conclusion

Table 1. Liposomal Amphoteracin B Annual Sales CAGR by Geographic Region (2017, 2022 & 2028) & ($ millions)

Table 2. Liposomal Amphoteracin B Annual Sales CAGR by Country/Region (2017, 2022 & 2028) & ($ millions)

Table 3. Major Players of 25mg

Table 4. Major Players of 50mg

Table 5. Global Liposomal Amphoteracin B Sales by Type (2017-2022) & (K Units)

Table 6. Global Liposomal Amphoteracin B Sales Market Share by Type (2017-2022)

Table 7. Global Liposomal Amphoteracin B Revenue by Type (2017-2022) & ($ million)

Table 8. Global Liposomal Amphoteracin B Revenue Market Share by Type (2017-2022)

Table 9. Global Liposomal Amphoteracin B Sale Price by Type (2017-2022) & (US$/Unit)

Table 10. Global Liposomal Amphoteracin B Sales by Application (2017-2022) & (K Units)

Table 11. Global Liposomal Amphoteracin B Sales Market Share by Application (2017-2022)

Table 12. Global Liposomal Amphoteracin B Revenue by Application (2017-2022)

Table 13. Global Liposomal Amphoteracin B Revenue Market Share by Application (2017-2022)

Table 14. Global Liposomal Amphoteracin B Sale Price by Application (2017-2022) & (US$/Unit)

Table 15. Global Liposomal Amphoteracin B Sales by Company (2020-2022) & (K Units)

Table 16. Global Liposomal Amphoteracin B Sales Market Share by Company (2020-2022)

Table 17. Global Liposomal Amphoteracin B Revenue by Company (2020-2022) ($ Millions)

Table 18. Global Liposomal Amphoteracin B Revenue Market Share by Company (2020-2022)

Table 19. Global Liposomal Amphoteracin B Sale Price by Company (2020-2022) & (US$/Unit)

Table 20. Key Manufacturers Liposomal Amphoteracin B Producing Area Distribution and Sales Area

Table 21. Players Liposomal Amphoteracin B Products Offered

Table 22. Liposomal Amphoteracin B Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

Table 23. New Products and Potential Entrants

Table 24. Mergers & Acquisitions, Expansion

Table 25. Global Liposomal Amphoteracin B Sales by Geographic Region (2017-2022) & (K Units)

Table 26. Global Liposomal Amphoteracin B Sales Market Share Geographic Region (2017-2022)

Table 27. Global Liposomal Amphoteracin B Revenue by Geographic Region (2017-2022) & ($ millions)

Table 28. Global Liposomal Amphoteracin B Revenue Market Share by Geographic Region (2017-2022)

Table 29. Global Liposomal Amphoteracin B Sales by Country/Region (2017-2022) & (K Units)

Table 30. Global Liposomal Amphoteracin B Sales Market Share by Country/Region (2017-2022)

Table 31. Global Liposomal Amphoteracin B Revenue by Country/Region (2017-2022) & ($ millions)

Table 32. Global Liposomal Amphoteracin B Revenue Market Share by Country/Region (2017-2022)

Table 33. Americas Liposomal Amphoteracin B Sales by Country (2017-2022) & (K Units)

Table 34. Americas Liposomal Amphoteracin B Sales Market Share by Country (2017-2022)

Table 35. Americas Liposomal Amphoteracin B Revenue by Country (2017-2022) & ($ Millions)

Table 36. Americas Liposomal Amphoteracin B Revenue Market Share by Country (2017-2022)

Table 37. Americas Liposomal Amphoteracin B Sales by Type (2017-2022) & (K Units)

Table 38. Americas Liposomal Amphoteracin B Sales Market Share by Type (2017-2022)

Table 39. Americas Liposomal Amphoteracin B Sales by Application (2017-2022) & (K Units)

Table 40. Americas Liposomal Amphoteracin B Sales Market Share by Application (2017-2022)

Table 41. APAC Liposomal Amphoteracin B Sales by Region (2017-2022) & (K Units)

Table 42. APAC Liposomal Amphoteracin B Sales Market Share by Region (2017-2022)

Table 43. APAC Liposomal Amphoteracin B Revenue by Region (2017-2022) & ($ Millions)

Table 44. APAC Liposomal Amphoteracin B Revenue Market Share by Region (2017-2022)

Table 45. APAC Liposomal Amphoteracin B Sales by Type (2017-2022) & (K Units)

Table 46. APAC Liposomal Amphoteracin B Sales Market Share by Type (2017-2022)

Table 47. APAC Liposomal Amphoteracin B Sales by Application (2017-2022) & (K Units)

Table 48. APAC Liposomal Amphoteracin B Sales Market Share by Application (2017-2022)

Table 49. Europe Liposomal Amphoteracin B Sales by Country (2017-2022) & (K Units)

Table 50. Europe Liposomal Amphoteracin B Sales Market Share by Country (2017-2022)

Table 51. Europe Liposomal Amphoteracin B Revenue by Country (2017-2022) & ($ Millions)

Table 52. Europe Liposomal Amphoteracin B Revenue Market Share by Country (2017-2022)

Table 53. Europe Liposomal Amphoteracin B Sales by Type (2017-2022) & (K Units)

Table 54. Europe Liposomal Amphoteracin B Sales Market Share by Type (2017-2022)

Table 55. Europe Liposomal Amphoteracin B Sales by Application (2017-2022) & (K Units)

Table 56. Europe Liposomal Amphoteracin B Sales Market Share by Application (2017-2022)

Table 57. Middle East & Africa Liposomal Amphoteracin B Sales by Country (2017-2022) & (K Units)

Table 58. Middle East & Africa Liposomal Amphoteracin B Sales Market Share by Country (2017-2022)

Table 59. Middle East & Africa Liposomal Amphoteracin B Revenue by Country (2017-2022) & ($ Millions)

Table 60. Middle East & Africa Liposomal Amphoteracin B Revenue Market Share by Country (2017-2022)

Table 61. Middle East & Africa Liposomal Amphoteracin B Sales by Type (2017-2022) & (K Units)

Table 62. Middle East & Africa Liposomal Amphoteracin B Sales Market Share by Type (2017-2022)

Table 63. Middle East & Africa Liposomal Amphoteracin B Sales by Application (2017-2022) & (K Units)

Table 64. Middle East & Africa Liposomal Amphoteracin B Sales Market Share by Application (2017-2022)

Table 65. Key Market Drivers & Growth Opportunities of Liposomal Amphoteracin B

Table 66. Key Market Challenges & Risks of Liposomal Amphoteracin B

Table 67. Key Industry Trends of Liposomal Amphoteracin B

Table 68. Liposomal Amphoteracin B Raw Material

Table 69. Key Suppliers of Raw Materials

Table 70. Liposomal Amphoteracin B Distributors List

Table 71. Liposomal Amphoteracin B Customer List

Table 72. Global Liposomal Amphoteracin B Sales Forecast by Region (2023-2028) & (K Units)

Table 73. Global Liposomal Amphoteracin B Sales Market Forecast by Region

Table 74. Global Liposomal Amphoteracin B Revenue Forecast by Region (2023-2028) & ($ millions)

Table 75. Global Liposomal Amphoteracin B Revenue Market Share Forecast by Region (2023-2028)

Table 76. Americas Liposomal Amphoteracin B Sales Forecast by Country (2023-2028) & (K Units)

Table 77. Americas Liposomal Amphoteracin B Revenue Forecast by Country (2023-2028) & ($ millions)

Table 78. APAC Liposomal Amphoteracin B Sales Forecast by Region (2023-2028) & (K Units)

Table 79. APAC Liposomal Amphoteracin B Revenue Forecast by Region (2023-2028) & ($ millions)

Table 80. Europe Liposomal Amphoteracin B Sales Forecast by Country (2023-2028) & (K Units)

Table 81. Europe Liposomal Amphoteracin B Revenue Forecast by Country (2023-2028) & ($ millions)

Table 82. Middle East & Africa Liposomal Amphoteracin B Sales Forecast by Country (2023-2028) & (K Units)

Table 83. Middle East & Africa Liposomal Amphoteracin B Revenue Forecast by Country (2023-2028) & ($ millions)

Table 84. Global Liposomal Amphoteracin B Sales Forecast by Type (2023-2028) & (K Units)

Table 85. Global Liposomal Amphoteracin B Sales Market Share Forecast by Type (2023-2028)

Table 86. Global Liposomal Amphoteracin B Revenue Forecast by Type (2023-2028) & ($ Millions)

Table 87. Global Liposomal Amphoteracin B Revenue Market Share Forecast by Type (2023-2028)

Table 88. Global Liposomal Amphoteracin B Sales Forecast by Application (2023-2028) & (K Units)

Table 89. Global Liposomal Amphoteracin B Sales Market Share Forecast by Application (2023-2028)

Table 90. Global Liposomal Amphoteracin B Revenue Forecast by Application (2023-2028) & ($ Millions)

Table 91. Global Liposomal Amphoteracin B Revenue Market Share Forecast by Application (2023-2028)

Table 92. Gilead Sciences Basic Information, Liposomal Amphoteracin B Manufacturing Base, Sales Area and Its Competitors

Table 93. Gilead Sciences Liposomal Amphoteracin B Product Offered

Table 94. Gilead Sciences Liposomal Amphoteracin B Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 95. Gilead Sciences Main Business

Table 96. Gilead Sciences Latest Developments

Table 97. Cipla Basic Information, Liposomal Amphoteracin B Manufacturing Base, Sales Area and Its Competitors

Table 98. Cipla Liposomal Amphoteracin B Product Offered

Table 99. Cipla Liposomal Amphoteracin B Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 100. Cipla Main Business

Table 101. Cipla Latest Developments

List of Figures

Figure 1. Picture of Liposomal Amphoteracin B

Figure 2. Liposomal Amphoteracin B Report Years Considered

Figure 3. Research Objectives

Figure 4. Research Methodology

Figure 5. Research Process and Data Source

Figure 6. Global Liposomal Amphoteracin B Sales Growth Rate 2017-2028 (K Units)

Figure 7. Global Liposomal Amphoteracin B Revenue Growth Rate 2017-2028 ($ Millions)

Figure 8. Liposomal Amphoteracin B Sales by Region (2021 & 2028) & ($ millions)

Figure 9. Product Picture of 25mg

Figure 10. Product Picture of 50mg

Figure 11. Global Liposomal Amphoteracin B Sales Market Share by Type in 2021

Figure 12. Global Liposomal Amphoteracin B Revenue Market Share by Type (2017-2022)

Figure 13. Liposomal Amphoteracin B Consumed in Hospital

Figure 14. Global Liposomal Amphoteracin B Market: Hospital (2017-2022) & (K Units)

Figure 15. Liposomal Amphoteracin B Consumed in Pharmacy

Figure 16. Global Liposomal Amphoteracin B Market: Pharmacy (2017-2022) & (K Units)

Figure 17. Global Liposomal Amphoteracin B Sales Market Share by Application (2017-2022)

Figure 18. Global Liposomal Amphoteracin B Revenue Market Share by Application in 2021

Figure 19. Liposomal Amphoteracin B Revenue Market by Company in 2021 ($ Million)

Figure 20. Global Liposomal Amphoteracin B Revenue Market Share by Company in 2021

Figure 21. Global Liposomal Amphoteracin B Sales Market Share by Geographic Region (2017-2022)

Figure 22. Global Liposomal Amphoteracin B Revenue Market Share by Geographic Region in 2021

Figure 23. Global Liposomal Amphoteracin B Sales Market Share by Region (2017-2022)

Figure 24. Global Liposomal Amphoteracin B Revenue Market Share by Country/Region in 2021

Figure 25. Americas Liposomal Amphoteracin B Sales 2017-2022 (K Units)

Figure 26. Americas Liposomal Amphoteracin B Revenue 2017-2022 ($ Millions)

Figure 27. APAC Liposomal Amphoteracin B Sales 2017-2022 (K Units)

Figure 28. APAC Liposomal Amphoteracin B Revenue 2017-2022 ($ Millions)

Figure 29. Europe Liposomal Amphoteracin B Sales 2017-2022 (K Units)

Figure 30. Europe Liposomal Amphoteracin B Revenue 2017-2022 ($ Millions)

Figure 31. Middle East & Africa Liposomal Amphoteracin B Sales 2017-2022 (K Units)

Figure 32. Middle East & Africa Liposomal Amphoteracin B Revenue 2017-2022 ($ Millions)

Figure 33. Americas Liposomal Amphoteracin B Sales Market Share by Country in 2021

Figure 34. Americas Liposomal Amphoteracin B Revenue Market Share by Country in 2021

Figure 35. United States Liposomal Amphoteracin B Revenue Growth 2017-2022 ($ Millions)

Figure 36. Canada Liposomal Amphoteracin B Revenue Growth 2017-2022 ($ Millions)

Figure 37. Mexico Liposomal Amphoteracin B Revenue Growth 2017-2022 ($ Millions)

Figure 38. Brazil Liposomal Amphoteracin B Revenue Growth 2017-2022 ($ Millions)

Figure 39. APAC Liposomal Amphoteracin B Sales Market Share by Region in 2021

Figure 40. APAC Liposomal Amphoteracin B Revenue Market Share by Regions in 2021

Figure 41. China Liposomal Amphoteracin B Revenue Growth 2017-2022 ($ Millions)

Figure 42. Japan Liposomal Amphoteracin B Revenue Growth 2017-2022 ($ Millions)

Figure 43. South Korea Liposomal Amphoteracin B Revenue Growth 2017-2022 ($ Millions)

Figure 44. Southeast Asia Liposomal Amphoteracin B Revenue Growth 2017-2022 ($ Millions)

Figure 45. India Liposomal Amphoteracin B Revenue Growth 2017-2022 ($ Millions)

Figure 46. Australia Liposomal Amphoteracin B Revenue Growth 2017-2022 ($ Millions)

Figure 47. Europe Liposomal Amphoteracin B Sales Market Share by Country in 2021

Figure 48. Europe Liposomal Amphoteracin B Revenue Market Share by Country in 2021

Figure 49. Germany Liposomal Amphoteracin B Revenue Growth 2017-2022 ($ Millions)

Figure 50. France Liposomal Amphoteracin B Revenue Growth 2017-2022 ($ Millions)

Figure 51. UK Liposomal Amphoteracin B Revenue Growth 2017-2022 ($ Millions)

Figure 52. Italy Liposomal Amphoteracin B Revenue Growth 2017-2022 ($ Millions)

Figure 53. Russia Liposomal Amphoteracin B Revenue Growth 2017-2022 ($ Millions)

Figure 54. Middle East & Africa Liposomal Amphoteracin B Sales Market Share by Country in 2021

Figure 55. Middle East & Africa Liposomal Amphoteracin B Revenue Market Share by Country in 2021

Figure 56. Egypt Liposomal Amphoteracin B Revenue Growth 2017-2022 ($ Millions)

Figure 57. South Africa Liposomal Amphoteracin B Revenue Growth 2017-2022 ($ Millions)

Figure 58. Israel Liposomal Amphoteracin B Revenue Growth 2017-2022 ($ Millions)

Figure 59. Turkey Liposomal Amphoteracin B Revenue Growth 2017-2022 ($ Millions)

Figure 60. GCC Country Liposomal Amphoteracin B Revenue Growth 2017-2022 ($ Millions)

Figure 61. Manufacturing Cost Structure Analysis of Liposomal Amphoteracin B in 2021

Figure 62. Manufacturing Process Analysis of Liposomal Amphoteracin B

Figure 63. Industry Chain Structure of Liposomal Amphoteracin B

Figure 64. Channels of Distribution

Figure 65. Distributors Profiles